Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial – The Lancet Invited Commentary: Azithromycin, RECOVERY, and the power of large, simple trials – The Lancet  

The post RECOVERY trial: Azithromycin not beneficial for patients admitted to hospital with COVID-19 appeared first on Links Medicus.